We are live on ! Find out more
UOC

UBS O'Connor Portfolio holdings

AUM $3.76B
1-Year Est. Return 62.41%
This Fund
S&P 500
This Quarter Est. Return
+3.87%
1 Year Est. Return
+62.41%
3 Year Est. Return
+179.84%
5 Year Est. Return
+371.69%
10 Year Est. Return
+1,534.25%
AUM
$4.81B
AUM Growth
-$531M
Cap. Flow
-$1.24B
Cap. Flow %
-25.85%
Top 10 Hldgs %
18.16%
Holding
673
New
167
Increased
91
Reduced
97
Closed
256
Avg Time Held Equity + Options
0.6 quarters
Top 10 Avg Time Held Equity + Options
0.6 quarters
Top 20 Avg Time Held Equity + Options
0.4 quarters
Avg Time Held Equity only
0.6 quarters
Top 10 Avg Time Held Equity only
0.6 quarters
Top 20 Avg Time Held Equity only
0.4 quarters

Top Buys

Rank Stock Value
1
CL icon
Colgate-Palmolive
CL
+$59.4M
2
ONXX
ONYX PHARMACEUTICALS INC
ONXX
+$56.3M
3
SPG icon
Simon Property Group
SPG
+$52M
4
TSM icon
TSMC
TSM
+$45.4M
5
M icon
Macy's
M
+$44.3M

Sector Composition

Rank Sector Weight
1 Miscellaneous 29.53%
2 Real Estate 16.41%
3 Consumer Staples 12.46%
4 Financials 6.75%
5 Consumer Discretionary 6.16%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
ZTS icon
526
Zoetis
ZTS
$30.9B
– –
-188,003
Closed -$5.81M –
SWN icon
527
DELISTED
Southwestern Energy Company
SWN
– –
-66,896
Closed -$2.44M –
SLCA icon
528
DELISTED
U.S. SILICA HOLDINGS, INC.
SLCA
– –
-37,187
Closed -$773K –
LBAI icon
529
DELISTED
Lakeland Bancorp Inc
LBAI
– –
-525,630
Closed -$5.22M –
AEL icon
530
DELISTED
American Equity Investment Life Holding Company
AEL
– –
-202,397
Closed -$3.18M –
MDC icon
531
DELISTED
M.D.C. Holdings, Inc.
MDC
– –
-467,019
Closed -$10.9M –
HT
532
DELISTED
Hersha Hospitality Trust Priority Class A Common Shares of Beneficial Interest
HT
– –
-221,937
Closed -$5.01M –
INFI
533
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
– –
-175,500
Closed -$2.85M –
BBBY
534
PUT
DELISTED
Bed Bath & Beyond Inc
BBBY
– –
-103,500
Closed -$98K –
ALBO
535
DELISTED
Albireo Pharma Inc
ALBO
– –
-9,000
Closed -$1.13M –
DRE
536
DELISTED
Duke Realty Corp.
DRE
– –
-64,497
Closed -$1.01M –
MTOR
537
DELISTED
MERITOR, Inc.
MTOR
– –
-39,600
Closed -$279K –
FMBI
538
DELISTED
First Midwest Bancorp Inc/IL
FMBI
– –
-658,235
Closed -$9.03M –
LORL
539
DELISTED
Loral Space and Communications, Inc.
LORL
– –
-15,652
Closed -$939K –
CSOD
540
DELISTED
Cornerstone OnDemand, Inc.
CSOD
– –
-118,000
Closed -$5.11M –
XEC
541
DELISTED
CIMAREX ENERGY CO
XEC
– –
-76,460
Closed -$4.97M –
WRI
542
DELISTED
Weingarten Realty Investors
WRI
– –
-562,321
Closed -$17.3M –
NAV
543
DELISTED
Navistar International
NAV
– –
-84,001
Closed -$2.33M –
HCAP
544
DELISTED
Harvest Capital Credit Corporation
HCAP
– –
-84,608
Closed -$1.28M –
GWPH
545
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
– –
-35,060
Closed -$304K –
TCO
546
DELISTED
Taubman Centers Inc.
TCO
– –
-210,824
Closed -$15.8M –
TTPH
547
DELISTED
Tetraphase Pharmaceuticals, Inc.
TTPH
– –
-1,550
Closed -$218K –
CHK icon
548
CALL
DELISTED
Chesapeake Energy Corporation
CHK
– –
-159
Closed -$3K –
PGNX
549
DELISTED
Progenics Pharmaceuticals Inc
PGNX
– –
-318,191
Closed -$1.42M –
AGN
550
DELISTED
Allergan plc
AGN
– –
-29,000
Closed -$3.66M –

Similar funds

UBS O'Connor's Q3 2013 Portfolio in Review

As of Q3 2013, UBS O'Connor held 673 positions worth $4.81B, down 9.9% from $5.34B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

UBS O'Connor withdrew a net $1.24B in Q3 2013, closing 256 positions and reducing 97 holdings. Its most notable exit was Pfizer, an estimated $167M position sold in full.

By sector, the portfolio is most concentrated in Miscellaneous at 30% of assets, up from 27% a quarter earlier, followed by Real Estate and Consumer Staples.

Against the trend, UBS O'Connor opened a new position in Colgate-Palmolive worth $59.4M.

  • UBS O'Connor's largest Q3 2013 buy was Colgate-Palmolive: 1,002,498 shares worth $59.4M.
  • UBS O'Connor added most to ONYX PHARMACEUTICALS INC in Q3 2013, an estimated $56.3M increase.
  • UBS O'Connor's biggest Q3 2013 reduction was Advance Auto Parts, cutting an estimated $48.2M.
  • UBS O'Connor fully exited Pfizer in Q3 2013, selling an estimated $167M.
  • UBS O'Connor's ten largest holdings make up 18% of its $4.81B portfolio in Q3 2013.
  • UBS O'Connor opened 167 new positions and closed 256 in Q3 2013.
  • UBS O'Connor's portfolio value fell 9.9% quarter-over-quarter to $4.81B.

Based on UBS O'Connor's 13F filing for Q3 2013, filed 14 Nov 2013.